<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="190178">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00617487</url>
  </required_header>
  <id_info>
    <org_study_id>EchostressSSc</org_study_id>
    <nct_id>NCT00617487</nct_id>
  </id_info>
  <brief_title>Pulmonary Arterial Hypertension in Systemic Sclerosis</brief_title>
  <official_title>Stress Echocardiography in the Early Identification of Pulmonary Arterial Hypertension in Systemic Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Policlinico S. Matteo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Policlinico S. Matteo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the role of stress echocardiography, compared to
      standard echocardiography in the early identification of pulmonary arterial hypertension in
      systemic sclerosis. To evaluate the role of BNP in this setting.To analyze data recorded
      with respect to the parameters commonly used for SSc evaluation (eg thorax HRCT, pulmonary
      function tests + DLCO, nailfold capillaroscopy, etc); these parameters are available
      starting for 1999.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2007</start_date>
  <completion_date type="Anticipated">January 2010</completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Systemic Sclerosis</condition>
  <condition>Pulmonary Arterial Hypertension</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients with systemic sclerosis
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with systemic sclerosis according to LeRoy criteria

        Exclusion Criteria:

          -  Pregnancy

          -  Significant valvular disease

          -  Low left ventricular function upon echocardiography (ejection fraction&lt;55%)

          -  History of atrial fibrillation, myocardial infarction, pulmonary thromboembolisms,
             neoplasia or severe hepatic disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefano Ghio, MD</last_name>
    <role>Study Director</role>
    <affiliation>IRCCS Foundation Policlinico S. Matteo, Cardiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lorenzo Cavagna, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University and IRCCS Foundation Policlinico S. Matteo, Rheumatology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lorenzo Cavagna, MD</last_name>
    <phone>00390382501878</phone>
    <email>lorenzo.cavagna@unipv.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>IRCCS Foundation Policlinico S. Matteo</name>
      <address>
        <city>Pavia</city>
        <state>PV</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lorenzo Cavagna, MD</last_name>
      <phone>00390382</phone>
      <phone_ext>501878</phone_ext>
      <email>lorenzo.cavagna@unipv.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>IRCCS Policlinico S. Matteo</name>
      <address>
        <city>Pavia</city>
        <state>PV</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Stefano Ghio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <lastchanged_date>August 3, 2009</lastchanged_date>
  <firstreceived_date>February 6, 2008</firstreceived_date>
  <responsible_party>
    <name_title>Dr Ghio Stefano</name_title>
    <organization>Cardiology Unit IRCCS Foundation Policlinico S. Matteo, Pavia</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
    <mesh_term>Scleroderma, Systemic</mesh_term>
    <mesh_term>Scleroderma, Diffuse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
